159 related articles for article (PubMed ID: 30784060)
1. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
[TBL] [Abstract][Full Text] [Related]
2. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y
Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393
[TBL] [Abstract][Full Text] [Related]
3. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
[TBL] [Abstract][Full Text] [Related]
5. Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
Shimada A; Iijima-Yamashita Y; Tawa A; Tomizawa D; Yamada M; Norio S; Watanabe T; Taga T; Iwamoto S; Terui K; Moritake H; Kinoshita A; Takahashi H; Nakayama H; Koh K; Goto H; Kosaka Y; Saito AM; Kiyokawa N; Horibe K; Hara Y; Oki K; Hayashi Y; Tanaka S; Adachi S
Int J Hematol; 2018 May; 107(5):586-595. PubMed ID: 29330746
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
[TBL] [Abstract][Full Text] [Related]
7. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study.
Imamura T; Iwamoto S; Kanai R; Shimada A; Terui K; Osugi Y; Kobayashi R; Tawa A; Kosaka Y; Kato K; Hori H; Horibe K; Oda M; Adachi S;
Br J Haematol; 2012 Oct; 159(2):204-10. PubMed ID: 22924344
[TBL] [Abstract][Full Text] [Related]
8. Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
Aoki T; Takahashi H; Tanaka S; Shiba N; Hasegawa D; Iwamoto S; Terui K; Moritake H; Nakayama H; Shimada A; Koh K; Goto H; Kosaka Y; Saito AM; Horibe K; Kinoshita A; Tawa A; Taga T; Adachi S; Tomizawa D
Br J Haematol; 2021 Apr; 193(1):176-180. PubMed ID: 32337716
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors in Childhood Acute Myeloid Leukemia; Experience from A Developing Country.
Ghafoor T; Khalil S; Farah T; Ahmed S; Sharif I
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1259. PubMed ID: 33085844
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
[TBL] [Abstract][Full Text] [Related]
11. Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.
Lazzarotto D; Candoni A; Nadali G; Pavan L; Lessi F; Mosna F; Simeone E; Ventura G; Gherlinzoni F; Semenzato G; Pizzolo G; Fanin R
Eur J Haematol; 2016 Jun; 96(6):586-92. PubMed ID: 26186084
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
[TBL] [Abstract][Full Text] [Related]
13. Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia.
Karlsson L; Forestier E; Hasle H; Jahnukainen K; Jónsson ÓG; Lausen B; Norén Nyström U; Palle J; Tierens A; Zeller B; Abrahamsson J
Br J Haematol; 2017 Aug; 178(4):592-602. PubMed ID: 28439893
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia.
Karlsson L; Cheuk D; De Moerloose B; Hasle H; Jahnukainen K; Juul-Dam KL; Kaspers G; Kovalova Z; Lausen B; Nyström UN; Palle J; Pronk CJ; Saks K; Tierens A; Zeller B; Abrahamsson J
Br J Haematol; 2023 May; 201(4):757-765. PubMed ID: 36762836
[TBL] [Abstract][Full Text] [Related]
15. NUP-98 Rearrangements Led to the Identification of Candidate Biomarkers for Primary Induction Failure in Pediatric Acute Myeloid Leukemia.
Barresi V; Di Bella V; Andriano N; Privitera AP; Bonaccorso P; La Rosa M; Iachelli V; Spampinato G; Pulvirenti G; Scuderi C; Condorelli DF; Lo Nigro L
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925480
[TBL] [Abstract][Full Text] [Related]
16. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.
Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H
Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946
[TBL] [Abstract][Full Text] [Related]
17. Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.
Brunner AM; Li S; Fathi AT; Wadleigh M; Ho VT; Collier K; Connolly C; Ballen KK; Cutler CS; Dey BR; El-Jawahri A; Nikiforow S; McAfee SL; Koreth J; Deangelo DJ; Alyea EP; Antin JH; Spitzer TR; Stone RM; Soiffer RJ; Chen YB
Br J Haematol; 2016 Nov; 175(3):496-504. PubMed ID: 27434660
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of foetal-like tyrosine kinase 3 mutation in Egyptian children with acute leukaemia.
Al-Tonbary Y; Mansour AK; Ghazy H; Elghannam DM; Abd-Elghaffar HA
Int J Lab Hematol; 2009 Jun; 31(3):320-6. PubMed ID: 18336585
[TBL] [Abstract][Full Text] [Related]
19. Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy.
Lim SJ; Lim MJ; Raptis A; Hou JZ; Farah R; Marks SM; Im A; Dorritie K; Sehgal A; Agha M; Felgar R; Lim SH
Am J Hematol; 2015 Aug; 90(8):715-8. PubMed ID: 26010177
[TBL] [Abstract][Full Text] [Related]
20. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
Alexander TB; Wang L; Inaba H; Triplett BM; Pounds S; Ribeiro RC; Pui CH; Rubnitz JE
Cancer; 2017 Oct; 123(19):3791-3798. PubMed ID: 28556917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]